Your browser doesn't support javascript.
loading
The cost-effectiveness of blue-light therapy in the treatment of mild-to-moderate psoriasis.
Ansaripour, Amir; Thio, Hok Bing; Maessen, Rob; Redekop, William Ken.
Afiliación
  • Ansaripour A; Institute for Medical Technology Assessment, Institute of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, The Netherlands.
  • Thio HB; Department of Dermatology, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Maessen R; Philips, Philips Light & Health, Eindhoven, The Netherlands.
  • Redekop WK; Institute for Medical Technology Assessment, Institute of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, The Netherlands.
J Comp Eff Res ; 6(4): 325-335, 2017 Jun.
Article en En | MEDLINE | ID: mdl-28452226
AIM: To investigate the cost-effectiveness of blue-light therapy versus a two-compound formulation (TCF) (Dovobet® gel [calcipotriol and betamethasone]) in mild-to-moderate psoriasis. METHODS: A Markov model was applied to describe the course of disease among Dutch patients with a Psoriasis Area and Severity Index (PASI) score ≤ 10 over a 52-week time horizon. Patients received either 12-week blue-light therapy or two 4-week treatments with TCF. Patients, experiencing no PASI reduction after either therapy, were assumed to receive 12-week ultraviolet B phototherapy. RESULTS: There was no significant difference in PASI reduction between two interventions (71 vs 72%). However, blue-light therapy was associated with a cost savings of EU€248. CONCLUSION: Treatment of mild-to-moderate chronic plaque psoriasis using blue-light therapy may be more cost-effective than TCF.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fototerapia / Psoriasis / Análisis Costo-Beneficio Tipo de estudio: Health_economic_evaluation / Prognostic_studies Límite: Humans País/Región como asunto: Europa Idioma: En Revista: J Comp Eff Res Año: 2017 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fototerapia / Psoriasis / Análisis Costo-Beneficio Tipo de estudio: Health_economic_evaluation / Prognostic_studies Límite: Humans País/Región como asunto: Europa Idioma: En Revista: J Comp Eff Res Año: 2017 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Reino Unido